Stuart Sayers - Cochlear Chief Officer

COH Stock   291.38  0.87  0.30%   

Insider

Stuart Sayers is Chief Officer of Cochlear
Address 1 University Avenue, Sydney, NSW, Australia, 2109
Phone61 2 9428 6555
Webhttps://www.cochlear.com

Cochlear Management Efficiency

The company has return on total asset (ROA) of 0.1199 % which means that it generated a profit of $0.1199 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1988 %, meaning that it generated $0.1988 on every $100 dollars invested by stockholders. Cochlear's management efficiency ratios could be used to measure how well Cochlear manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Cochlear's Total Current Liabilities is comparatively stable compared to the past year. Liabilities And Stockholders Equity is likely to gain to about 2.9 B in 2024, whereas Non Current Liabilities Other is likely to drop slightly above 92 M in 2024.
Cochlear has accumulated 243.7 M in total debt. Debt can assist Cochlear until it has trouble settling it off, either with new capital or with free cash flow. So, Cochlear's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Cochlear sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Cochlear to invest in growth at high rates of return. When we think about Cochlear's use of debt, we should always consider it together with cash and equity.

Similar Executives

Found 3 records

INSIDER Age

CA BEconAurelia Metals
N/A
MAusIMM BEngAurelia Metals
N/A
Andrew GrahamAurelia Metals
N/A
Cochlear (COH) is traded on Australian Securities Exchange in Australia and employs 4,996 people. Cochlear is listed under Health Care Equipment & Supplies category by Fama And French industry classification.

Management Performance

Cochlear Leadership Team

Elected by the shareholders, the Cochlear's board of directors comprises two types of representatives: Cochlear inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Cochlear. The board's role is to monitor Cochlear's management team and ensure that shareholders' interests are well served. Cochlear's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Cochlear's outside directors are responsible for providing unbiased perspectives on the board's policies.
Karen ODriscoll, Chief Officer
Stuart Sayers, Chief Officer
Dean Phizacklea, Senior Marketing
Jennifer Hornery, Senior Culture
Richard MBA, Pres EMEA
Jan Eng, Chief Officer
Jennifer Stevenson, VP Brand
Rob McGrory, Group Secretary
Kristina Devon, Vice Relations
Lisa Aubert, President America
MBA BE, MD, CEO
David Hackshall, Chief Officer
Anthony Bishop, Pres America
Brian Kaplan, Senior Innovation
MComm BE, Senior Chain

Cochlear Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Cochlear a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Cochlear Stock Analysis

When running Cochlear's price analysis, check to measure Cochlear's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cochlear is operating at the current time. Most of Cochlear's value examination focuses on studying past and present price action to predict the probability of Cochlear's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cochlear's price. Additionally, you may evaluate how the addition of Cochlear to your portfolios can decrease your overall portfolio volatility.